Stealth BioTherapeutics Corp
Patents, Design & Utilities

Last updated:

List of all Stealth BioTherapeutics Corp patents 62 in total

Status Patent
Grant
Utility: Methods for the regulation of matrix metalloproteinase expression External link
Filling date: 9 Sep 2025 Issue date: 7 Jan 2020
Application
Utility: METHODS FOR TREATMENT OF ATHEROSCLEROSIS External link
Filling date: 9 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA External link
Filling date: 9 Sep 2025 Issue date: 26 Dec 2019
Application
Utility: PEPTIDE THERAPEUTICS AND METHODS FOR USING SAME External link
Filling date: 9 Sep 2025 Issue date: 12 Dec 2019
Application
Utility: METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY External link
Filling date: 9 Sep 2025 Issue date: 5 Dec 2019
Application
Utility: METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE External link
Filling date: 9 Sep 2025 Issue date: 5 Dec 2019
Application
Utility: METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING External link
Filling date: 9 Sep 2025 Issue date: 28 Nov 2019
Application
Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY External link
Filling date: 9 Sep 2025 Issue date: 14 Nov 2019
Application
Utility: METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY External link
Filling date: 9 Sep 2025 Issue date: 7 Nov 2019
Application
Utility: METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING DOMINANT OPTIC ATROPHY External link
Filling date: 9 Sep 2025 Issue date: 31 Oct 2019
Application
Utility: COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES External link
Filling date: 9 Sep 2025 Issue date: 12 Sep 2019
Application
Utility: CRYSTALLINE BIS- AND TRIS-HYDROCHLORIDE SALT OF ELAMIPRETIDE External link
Filling date: 9 Sep 2025 Issue date: 1 Aug 2019

Showing 50 to 62 of 62 patents.